Disclosures: The authors have no conflict of interest and received no financial support for this manuscript.
Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model
Version of Record online: 28 FEB 2013
© 2013 The Japan Society of Hepatology
Volume 43, Issue 11, pages 1241–1250, November 2013
How to Cite
Aihara, Y., Yoshiji, H., Noguchi, R., Kaji, K., Namisaki, T., Shirai, Y., Douhara, A., Moriya, K., Kawaratani, H. and Fukui, H. (2013), Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model. Hepatology Research, 43: 1241–1250. doi: 10.1111/hepr.12081
- Issue online: 28 OCT 2013
- Version of Record online: 28 FEB 2013
- Accepted manuscript online: 29 JAN 2013 05:52AM EST
- Manuscript Accepted: 21 JAN 2013
- Manuscript Revised: 16 JAN 2013
- Manuscript Received: 13 SEP 2012
Figure S1 Effect of DRI on CDAA-induced liver steatosis.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.